Release Date
Geography
Language of Resource
Full Text Available
Open Access / OK to Reproduce
Peer Reviewed
Objective
We compared prescription opioid pain medication dispensing for patients with schizophrenia (SZ) or bipolar disorder (BD) versus controls over 5 years, to assess opioid dispensing trends and comorbidities.
Findings/Key points
Patients with SZ or BD had a higher prevalence of comorbidities, including pain, versus controls in each analysis year. The proportions of individuals dispensed chronic or nonchronic opioid medications each year were similar between commercially and Medicaid-insured patients with SZ versus controls and were higher for patients with BD versus controls. From 2015 to 2019, the proportions of individuals who were dispensed prescription opioids chronically or nonchronically decreased for patients with SZ or BD and controls.
Design/methods
A retrospective, observational study, analyzing data from several medical and administrative databases, for people age 18-64 with SZ or BD through 2015-2019.